The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte BINIE V. LIPPS and
FREDERICK W. LIPPS
__________
Appeal No. 2006-2644
Application No. 09/047,945
__________
ON BRIEF
__________
Before SCHEINER, GRIMES, and LEBOVITZ, Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This appeal involves claims to a method of reducing serum IgE in a patient,
which the examiner has rejected as nonenabled. We have jurisdiction under 35 U.S.C.
§ 134. We affirm.
Background
“IgE is a minor component of total immunoglobulins and it is implicated in
allergies, which in some cases manifests as asthma. . . . Normal adults have 0.2 to
1.0 mg% of IgE. Currently 20% of the US population has higher than the normal range
of IgE and the percentage is increasing every year.” Specification, page 1.
Page: 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007